A Phase 4, Open-Label, Single Arm, Observational Study Evaluating the Effectiveness and Safety of Enbrel (Etanercept) 50 mg Once Weekly in Rheumatoid Arthritis Subjects Who Have Failed Remicade (Infliximab)
Phase of Trial: Phase IV
Latest Information Update: 12 Nov 2009
At a glance
- Drugs Etanercept (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 16 Oct 2008 Checked against ClinicalTrials.gov record, last updated 16 October 2008.
- 30 Aug 2007 Status change from recruiting to completed.
- 12 Oct 2005 New trial record.